P

Inventor

DARWISH IHAB

US32 patents
⚠️ This page may combine multiple inventors who share the name “DARWISH IHAB”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RIGEL PHARMACEUTICALS INC

28 patents
US10975064B2Apr 13, 2021

RIP1 inhibitory compounds and methods for making and using the same

RIGEL PHARMACEUTICALS INC14 citations86
US11407736B2Aug 9, 2022

RIP1 inhibitory compounds and methods for making and using the same

RIGEL PHARMACEUTICALS INC4 citations84
US9475781B2Oct 25, 2016

Fumarate analogs and uses thereof

RIGEL PHARMACEUTICALS INC11 citations84
US11584758B2Feb 21, 2023

RIP1K inhibitors

RIGEL PHARMACEUTICALS INC5 citations73
US11110082B2Sep 7, 2021

Tyrosine kinase inhibitors

RIGEL PHARMACEUTICALS INC2 citations73
US10822337B2Nov 3, 2020

TGF-β inhibitorC

RIGEL PHARMACEUTICALS INC4 citations73
US10434096B2Oct 8, 2019

Tyrosine kinase inhibitors

RIGEL PHARMACEUTICALS INC2 citations73
US10130623B2Nov 20, 2018

Tyrosine kinase inhibitors

RIGEL PHARMACEUTICALS INC2 citations73
US9801866B2Oct 31, 2017

Fumarate analogs and uses thereof

RIGEL PHARMACEUTICALS INC3 citations73
US11370787B2Jun 28, 2022

Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations

RIGEL PHARMACEUTICALS INC4 citations71
US11919890B2Mar 5, 2024

RIP1 inhibitory compounds and methods for making and using the same

RIGEL PHARMACEUTICALS INC1 citations63
US12297202B2May 13, 2025

RIP1K inhibitors

RIGEL PHARMACEUTICALS INC0 citations62
US12227508B2Feb 18, 2025

TGF-β inhibitors

RIGEL PHARMACEUTICALS INC0 citations62
US11672791B2Jun 13, 2023

Tyrosine kinase inhibitors

RIGEL PHARMACEUTICALS INC0 citations62
US11667643B2Jun 6, 2023

RIP1K inhibitors

RIGEL PHARMACEUTICALS INC0 citations62
US11466018B2Oct 11, 2022

TGF-β inhibitors

RIGEL PHARMACEUTICALS INC0 citations62
US11129819B2Sep 28, 2021

Fumarate analogs and uses thereof

RIGEL PHARMACEUTICALS INC0 citations62
US12043629B2Jul 23, 2024

RIP1K inhibitors

RIGEL PHARMACEUTICALS INC0 citations61
US12357623B2Jul 15, 2025

Method for treating a disease or condition using a pyrazole compound or formulation thereof

RIGEL PHARMACEUTICALS INC0 citations60
US7776847B2Aug 17, 2010

Benzisothiazoles useful for treating or preventing HCV infection

RIGEL PHARMACEUTICALS INC3 citations59
US10889562B2Jan 12, 2021

Prodrugs of Nrf2 activating compounds and uses thereof

RIGEL PHARMACEUTICALS INC0 citations56
US11578078B2Feb 14, 2023

Heterocyclic RIP1 inhibitory compounds

RIGEL PHARMACEUTICALS INC0 citations52
US11564930B2Jan 31, 2023

RIP1 inhibitory compounds and methods for making and using the same

RIGEL PHARMACEUTICALS INC0 citations52
US10493066B2Dec 3, 2019

Fumarate analogs and uses thereof

RIGEL PHARMACEUTICALS INC0 citations52
US9624229B2Apr 18, 2017

Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

RIGEL PHARMACEUTICALS INC0 citations52
US12459941B2Nov 4, 2025

Tricyclic IRAK inhibitors

RIGEL PHARMACEUTICALS INC0 citations47
US10774066B2Sep 15, 2020

Prodrugs of NRF2 activating compounds and uses thereof

RIGEL PHARMACEUTICALS INC0 citations45
US10851093B2Dec 1, 2020

Tyrosine kinase inhibitors

RIGEL PHARMACEUTICALS INC0 citations42

BHAMIDIPATI SOMASEKHAR

2 patents

UNIV CITY NEW YORK RES FOUND

1 patent

CELLTECH R & D INC

1 patent